Julphar Bangladesh Ltd. Julphar Bangladesh Ltd.
Career

Julphar Bangladesh Holds CME on “EASL 2017

Julphar Bangladesh Holds CME on “EASL 2017 Clinical Practice Guideline on the Management of Hepatitis-B Virus Infection” As part of its commitment to support healthcare professionals (HCPs) and provide patients with high quality and affordable products, Julphar Bangladesh organized... Read More

Julphar Bangladesh Holds CME on “Management of Chronic Hepatitis B Virus Infection-an Update”

As part of its commitment to support healthcare professionals (HCPs) and provide patients with high quality and affordable products, Julphar Bangladesh organized a CME on “Management of Chronic Hepatitis B Virus Infection-an Update” at Rangpur Medical College & Hospital on 18 may,... Read More

Julphar Bangladesh participated BD-ECHO Conference 2017

As a part of the company’s commitment to support and provide healthcare professionals with high quality and latest product, Julphar Bangladesh participated in BD-ECHO 2017 an International Conference in Echocardiography. This event took place on May 12th-13th, 2017 in Pan Pacific Sonargaon... Read More

Livercon 2017

Julphar Bangladesh Ltd. has taken part in the LIVERCON-2017 & 13th Annual Conference & Scientific Seminar at Bangabandhu Sheikh Mujib Medical University campus, Dhaka on 4th March 2017. This program was organized by Association for the Study of Liver Diseases, Bangladesh. The program... Read More

Gastrocon 2017

Julphar Bangladesh Ltd. has taken part in the 24th Annual Convention & Scientific Seminar of BGS at BICC, Dhaka on 11th & 12th February 2017. The program was organized by Bangladesh Gastroenterology Society (BGS). This program includes two days long scientific sessions presented by elite... Read More

Julphar Healthcare Organized a CME on MEBO in Jessore

As a part of the company’s commitment to support and provide healthcare professionals with high quality and latest product, Julphar Healthcare, a sister concern of Julphar Bangladesh  Ltd organized a CME on MEBO in Jessore on 12th April, 2017. Dr. Aminul Islam, Asst. Professor, Jessore... Read More

Celebration of Doxair 200 Launching Program

Julphar Bangladesh has celebrated launching program Doxair 200 (Doxophylline 200 mg) tablet, held in 45 medical institutes from 8th March to 11th March,countrywide.The launching ceremonies have been arranged mainly in ENT, Respiratory, Medicine units of Medical College Hospitals, Sadar Hospitals,... Read More

Juphar Bangladesh Arranged Free Diabetes Camp in Khulna

For creating awareness among poor people regarding “Diabetes and its complication”, Chronic Care Division of Julphar Bangladesh has been organized a “Free Diabetes Camp” in Khulna, Bangladesh on 30th March, 2017. Dr. M B Jaman, a leading Endocrinologist from Diabetic... Read More

Celebration of Roxibac Plus launching ceremony

Julphar Bangladesh has celebrated Roxibac Plus launching program in 163 major institutes of the country. These programs have been arranged mainly in ENT, Gynae, Medicine and Surgery units of Medical College Hospitals, Sadar Hospitals, Specialized Hospitals, Thana Health Complexes and Maternity... Read More

Julphar Bangladesh has introduced Roxibac Plus (Cefuroxime + Clavulanic acid)

  Julphar Bangladesh is passionate to introduce new and better molecules, strengths & dosage forms of various therapies in the market. Another feather of this effort is Roxibac Plus (Cefuroxime & Clavulanic acid) the most trusted antibiotic combination as Roxibac Plus 250 &... Read More

Julphar Bangladesh “Intensiva Division” has organized a CME on Infections control in ICU

    On March 15th, 2017 Julphar Bangladesh- Intensiva Division organized a CME program at Shaheed Suhrawardy Medical College & Hospital on Infections control in ICU with an audience of 43 Doctors. The event, which took place in Dhaka, was part of the company’s commitment to... Read More

Julphar Bangladesh has launched Doxair 200;a novophylline, ensures easy breathing

Julphar Bangladesh relentlessly thriving not only with new molecules but also with newer strength. As a continuation on 8th March, 2017 Julphar Bangladesh has launched  Doxair 200 (Doxophylline 200 mg), a novophylline ensuring easy breathing. Doxophylline, a new generation... Read More

Celebration of Maxwel launching ceremony

Julphar Bangladesh has celebrated Maxwel launching program in 155 major institutes of the country. These programs have been arranged mainly in Medicine and Gynae units of Medical College Hospitals, Sadar Hospitals, Specialized Hospitals and Thana Health Complexes.        In... Read More

Julphar Bangladesh Launched Eltrom (Eltrombopag) in Bangladesh

Through relentless efforts and our devotion to introduce the latest molecules in Bangladesh, Julphar Bangladesh introduced Eltrom (Eltrombopag 25 mg) tablet to treat patients with thrombocytopenia.   Eltrombopag was initially approved by the U.S. Food and Drug Administration on November 20,... Read More

Julphar Bangladesh have launched Maxwel, a complete multivitamin & multimineral supplement

  Julphar Bangladesh has introduced another new product Maxwel, for maximum well-being, a complete multivitamin & multimineral supplement with accurate balance of RDA. In many instances regular diet isn’t enough to meet the requirements of all key health benefits like... Read More

Celebration of Refla 24 launching ceremony

Julphar Bangladesh has celebrated Refla 24 mg launching program in 168 major institutes of the country.We have arranged these programs in Orthopedics, ENT & Medicine, and Respiratory units of Medical College Hospitals, Sadar Hospitals, Specialized Hospitals and Thana Health... Read More

Julphar Bangladesh have launched Refla 24, A Safer Steroid

Considering the safety profile, in July 2015 Julphar Bangladesh launched Refla, a safer anti-inflammatory steroid, preparation of Deflazacort 6 mg tablet. In acute inflammatory and allergic disorders recommended initial dose of Deflazacort is up to 120 mg daily. In acute bronchial asthma... Read More

Julphar Bangladesh Launched Velpacee (Velpatasvir+Sofosbuvir) 1st time in Bangladesh

Through relentless effort and our devotion to introduce the latest molecules in Bangladesh for the treatment of Hepatitis C, first time in Bangladesh, Julphar Bangladesh introduced blockbuster product Velpacee (Velpatasvir 100 mg & Sofosbuvir 400 mg) tablet. We have introduced the product with... Read More

Julphar Bangladesh launched Nexanib, a new class of drug of targeted therapy for HCC

  After successful introduction of Hepatitis C product in our virology portfolio from 2015, we are the consistent leader in this Hepatitis C market. Now, Julphar Bangladesh has launched another new class of drug of targeted therapy the name is Nexanib 200 (Sorafenib 200 mg) tablet for the... Read More

Julphar Bangladesh has Launched Butamirate Citrate (Butasiv 50 mg Tablet & 100 ml Syrup)

Julphar Bangladesh has launched another breakthrough Molecule Butamirate Citrate (Butasiv 50 mg Tablet & 100 ml Syrup) for Better management of cough.       Solution for all types of cough   Suppresses cough centre Expectorates sputum by relaxing bronchial... Read More

Julphar Bangladesh has Launched antiviral drug- Entecavir (Enbee 0.5mg Tablet)

After successful introduction of Hepatitis C product in our virology portfolio from 2015, we are the consistent leader in this Hepatitis C market. Now, Julphar Bangladesh has launched antiviral drug Enbee 0.5 (Entecavir 0.5 mg) tablet for the treatment of Hepatitis B viral... Read More

Julphar Bangladesh collaborates to improve availability of high quality medicines in Bangladesh

Julphar Bangladesh, subsidiary of the Ras Al Khaimah-based generic pharmaceutical company Julphar Gulf Pharmaceutical Industries, is pleased to announce the strategic toll agreement with the Bangladeshi nonprofit private limited company SMC Enterprise Limited (SMC-EL) to manufacture pharmaceutical... Read More

Julphar Bangladesh Launched Super Antioxidant- Greenox (Astaxanthin 4mg Capsule)

Julphar Bangladesh has launched Super Antioxidant Greenox- (Astaxanthin 4mg Capsule)    Live Green with Super Antioxidant   800 times stronger than CoQ10 6000 times stronger than Vitamin C 550 times stronger than Vitamin E Superior cell protector Most stable... Read More

Julphar Bangladesh Launched latest Methylxanthine- Doxair (Doxophylline 400 mg Tablet)

Julphar Bangladesh has launched another breakthrough Molecule Doxair (Doxophylline 400 mg Tablet) for Better management of Asthma & COPD Provides both Bronchodilatory and Anti-inflammatory effect Shows outstanding efficacy in Asthma & COPD Ensures Cardiac safety Ensures normal... Read More

Julphar Bangladesh Launched- Daclacee (first time in Bangladesh)

To extend the horizon of Antiviral treatment Julphar Bangladesh has launched another breakthrough Antiviral product Daclacee (Daclatavir 60 mg) first time in Bangladesh. Provide Pangenotypic anti-HCV activity High SVR rate Less treatment duration and cost Convenient oral treatment... Read More

Julphar Bangladesh have launched a safer steroid, Refla

Julphar Bangladesh Ltd. (previous RAK pharmaceuticals Pvt. Ltd.) has partnered with global pharmaceutical leader Hetero drugs, with the vision of diversifying its growth to better serve our communities, in need of fighting back diseases to restore healthy and productive life. As... Read More

Julphar Bangladesh the first company in Bangladesh with GMP compliance certification from the UAE, Ministry

GCC countries import medicines mainly from USA, UK & highly regulated countries. Their strict adherence to the medicines from the western world, stringent evaluation process of manufacturing facilities, practice, procedures and documentation to ascertain the implementation of rigorous... Read More

Julphar Bangladesh launched a novel antiemetic, Palorex

It is our great pleasure to inform that we have launched Palorex 0.5 mg tablet preparation of Palonosetron HCL, a latest antiemetic, which is long-acting and highly effective in -5HT3 receptor antagonist. Palorex controls nausea and vomiting with safety because it has no congenital and... Read More

Julphar Bangladesh launched a novel antihistamine, Rinobas

It is our great pleasure to inform that we are going to launch Rinobas 10 mg tablet preparation of Ebastine, a latest novel antihistamine, which is long-acting and highly selective H1-histamine receptor antagonist. Rinobas controls allergic conditions with safety because it has no CNS and... Read More


Last Update: 27 Jun 2017

© Julphar Bangladesh Ltd. 2008 - 2017. All Rig hts Reserved.
Developed By : Alien BD Inforamtion & Technology